16 related articles for article (PubMed ID: 38433050)
1. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
2. Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis.
He X; Pang Z; Zhang X; Lan T; Chen H; Chen M; Yang H; Huang J; Chen Y; Zhang Z; Jing W; Peng R; Zhang H
Am J Surg Pathol; 2018 Sep; 42(9):1143-1155. PubMed ID: 30001240
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of MDM2 RNA in situ hybridization for low-grade osteosarcoma: Consistency comparison of RNA in situ hybridization, fluorescence in situ hybridization, and immunohistochemistry.
Chen C; He X; Chen M; Du T; Qin W; Jing W; Zhang H
Virchows Arch; 2023 Jun; 482(6):999-1010. PubMed ID: 36977943
[TBL] [Abstract][Full Text] [Related]
4. Gene amplification and tumor grading in parosteal osteosarcoma.
Chen PC; Yen CC; Hung GY; Pan CC; Chen WM
J Chin Med Assoc; 2019 Dec; 82(12):889-894. PubMed ID: 31634336
[TBL] [Abstract][Full Text] [Related]
5. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
Li L; Zhang M; Zhang TT; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
[No Abstract] [Full Text] [Related]
6. [Detection of MDM2 gene amplification by fluorescence in situ hybridization and its diagnostic value in low-grade osteosarcoma].
Li L; Zhang M; Dong RF; Su YB; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):237-242. PubMed ID: 38433050
[No Abstract] [Full Text] [Related]
7. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches.
Romeo S; Bovée JV; Kroon HM; Tirabosco R; Natali C; Zanatta L; Sciot R; Mertens F; Athanasou N; Alberghini M; Szuhai K; Hogendoorn PC; Dei Tos AP
Virchows Arch; 2012 Nov; 461(5):561-70. PubMed ID: 23001328
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
